Receiver-operating characteristic analysis showed that the combination of CCP2 and CCP3 ELISA did not result in better discrimination between RA and controls than with individual CCP assays (AUC 0.79, 95% CI 0.78–0.81). The gene discussed is AGBL2; the disease is rheumatoid arthritis.